Shares of Rxo Inc (NYSE:RXO - Get Free Report) have received an average recommendation of "Hold" from the nineteen research firms that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $16.4667.
RXO has been the subject of a number of research reports. Benchmark reissued a "hold" rating on shares of RXO in a research note on Monday, February 9th. Citigroup upped their target price on shares of RXO from $15.00 to $18.00 and gave the company a "neutral" rating in a research report on Monday, February 9th. Wall Street Zen lowered RXO from a "hold" rating to a "sell" rating in a research report on Saturday, November 8th. Susquehanna upped their price objective on RXO from $10.00 to $11.00 and gave the company a "negative" rating in a research report on Thursday, January 8th. Finally, Wolfe Research raised RXO from an "underperform" rating to a "peer perform" rating in a research note on Friday, November 14th.
Read Our Latest Research Report on RXO
Institutional Investors Weigh In On RXO
Hedge funds and other institutional investors have recently made changes to their positions in the company. Royal Bank of Canada lifted its holdings in shares of RXO by 14.3% in the 1st quarter. Royal Bank of Canada now owns 23,251 shares of the company's stock worth $444,000 after acquiring an additional 2,902 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in RXO by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 94,940 shares of the company's stock worth $1,813,000 after purchasing an additional 4,134 shares during the period. Geneos Wealth Management Inc. purchased a new stake in RXO in the 1st quarter worth about $30,000. Strs Ohio bought a new stake in RXO in the first quarter worth about $97,000. Finally, AlphaQuest LLC purchased a new position in shares of RXO during the second quarter valued at approximately $29,000. Hedge funds and other institutional investors own 92.73% of the company's stock.
RXO Trading Down 6.2%
RXO stock opened at $15.50 on Friday. RXO has a 1 year low of $10.43 and a 1 year high of $20.58. The firm's 50 day moving average price is $14.92 and its 200-day moving average price is $15.15. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.27 and a quick ratio of 1.27. The stock has a market cap of $2.54 billion, a P/E ratio of -26.72, a PEG ratio of 11.61 and a beta of 1.67.
RXO (NYSE:RXO - Get Free Report) last posted its earnings results on Friday, February 6th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.03). RXO had a negative net margin of 1.74% and a negative return on equity of 0.44%. The company had revenue of $1.47 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same period in the previous year, the business posted $0.06 earnings per share. The business's revenue was down 11.9% on a year-over-year basis. On average, equities analysts predict that RXO will post 0.31 earnings per share for the current fiscal year.
RXO Company Profile
(
Get Free Report)
RXO Inc NYSE: RXO is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.